Literature DB >> 12089553

Generation of histocompatible tissues using nuclear transplantation.

Robert P Lanza1, Ho Yun Chung, James J Yoo, Peter J Wettstein, Catherine Blackwell, Nancy Borson, Erik Hofmeister, Gunter Schuch, Shay Soker, Carlos T Moraes, Michael D West, Anthony Atala.   

Abstract

Nuclear transplantation (therapeutic cloning) could theoretically provide a limitless source of cells for regenerative therapy. Although the cloned cells would carry the nuclear genome of the patient, the presence of mitochondria inherited from the recipient oocyte raises questions about the histocompatibility of the resulting cells. In this study, we created bioengineered tissues from cardiac, skeletal muscle, and renal cells cloned from adult bovine fibroblasts. Long-term viability was demonstrated after transplantation of the grafts into the nuclear donor animals. Reverse transcription-PCR (RT-PCR) and western blot analysis confirmed that the cloned tissues expressed tissue-specific mRNA and proteins while expressing a different mitochondrial DNA (mtDNA) haplotype. In addition to creating skeletal muscle and cardiac "patches", nuclear transplantation was used to generate functioning renal units that produced urinelike fluid and demonstrated unidirectional secretion and concentration of urea nitrogen and creatinine. Examination of the explanted renal devices revealed formation of organized glomeruli- and tubule-like structures. Delayed-type hypersensitivity (DTH) testing in vivo and Elispot analysis in vitro suggested that there was no rejection response to the cloned renal cells. The ability to generate histocompatible cells using cloning techniques addresses one of the major challenges in transplantation medicine.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12089553     DOI: 10.1038/nbt703

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  61 in total

Review 1.  Stem cells and cardiac repair: a critical analysis.

Authors:  Jonathan H Dinsmore; Nabil Dib
Journal:  J Cardiovasc Transl Res       Date:  2008-01-31       Impact factor: 4.132

Review 2.  Why the apparent haste to clone humans?

Authors:  N Cobbe
Journal:  J Med Ethics       Date:  2006-05       Impact factor: 2.903

3.  The future of organ replacement: needs, potential applications, and obstacles to application.

Authors:  M Cascalho; J L Platt
Journal:  Transplant Proc       Date:  2006-03       Impact factor: 1.066

Review 4.  Current progress with primate embryonic stem cells.

Authors:  James A Byrne; Shoukhrat M Mitalipov; Don P Wolf
Journal:  Curr Stem Cell Res Ther       Date:  2006-05       Impact factor: 3.828

5.  Organogenesis forum lecture: In vitro kidney development, tissue engineering and systems biology.

Authors:  Sanjay K Nigam; Wei Wu; Kevin T Bush
Journal:  Organogenesis       Date:  2008-07       Impact factor: 2.500

Review 6.  The pharmacology of regenerative medicine.

Authors:  George J Christ; Justin M Saul; Mark E Furth; Karl-Erik Andersson
Journal:  Pharmacol Rev       Date:  2013-07-01       Impact factor: 25.468

Review 7.  Concise review: stem/progenitor cells for renal tissue repair: current knowledge and perspectives.

Authors:  Shikhar Aggarwal; Aldo Moggio; Benedetta Bussolati
Journal:  Stem Cells Transl Med       Date:  2013-10-28       Impact factor: 6.940

Review 8.  Immune problems in central nervous system cell therapy.

Authors:  Roger A Barker; Håkan Widner
Journal:  NeuroRx       Date:  2004-10

9.  Couplet alignment and improved electrofusion by dielectrophoresis for a zona-free high-throughput cloned embryo production system.

Authors:  P Gaynor; D N Wells; B Oback
Journal:  Med Biol Eng Comput       Date:  2005-01       Impact factor: 2.602

Review 10.  Sources of stem cells for regenerative medicine.

Authors:  Jennifer Hipp; Anthony Atala
Journal:  Stem Cell Rev       Date:  2008       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.